Courageous Discourse™ with Dr. Peter McCullough & John Leake

Share this post

Courageous Discourse™ with Dr. Peter McCullough & John Leake
Courageous Discourse™ with Dr. Peter McCullough & John Leake
Low RSV Vaccine Acceptance Among Pregnant Women
Copy link
Facebook
Email
Notes
More

Low RSV Vaccine Acceptance Among Pregnant Women

Wary of Fever and Pregnancy Loss, Discerning Mothers Declining the Novel Shot

Peter A. McCullough, MD, MPH
Jan 10, 2024
233

Share this post

Courageous Discourse™ with Dr. Peter McCullough & John Leake
Courageous Discourse™ with Dr. Peter McCullough & John Leake
Low RSV Vaccine Acceptance Among Pregnant Women
Copy link
Facebook
Email
Notes
More
21
20
Share
Article voiceover
1×
0:00
-2:37
Audio playback is not supported on your browser. Please upgrade.

By Peter A. McCullough, MD, MPH

Vaccination during the third trimester of pregnancy is unprecedented and risky, since a vaccine induced fever could precipitate stillbirth or premature delivery of the baby. The CDC and the Bio-Pharmaceutical Complex has told young mothers they should take the risk for theoretical protect of the newborn.

As of August 30, 2023, the CDC recommends: “Vaccination for pregnant people, 1 dose of maternal RSV vaccine during weeks 32 through 36 of pregnancy, administered immediately before or during RSV season. Abrysvo is the only RSV vaccine recommended during pregnancy.” Now the CDC is reporting that only Asian women in the US have topped 10% on the respiratory syncytial virus RSV vaccination rate while African American mothers remain the most conservative with under 5% rates of acceptance. For any mass vaccination campaign, these data would indicate a program failure. The mothers and families have been burned by genetic COVID-19 vaccines and unprecedented rates of injury, disability, and death. There is little appetite for a new vaccine during pregnancy among obstetricians, midwives, and expecting mothers.

CDC.Gov accessed January 3, 2023

These data on the lagging maternal RSV immunization campaign indicate that “vaccine mania” may be cooling in the United States. As a consulting internist and cardiologist, I do not recommend the new RSV vaccine for pregnant women. There are insufficient data on short and longer term safety. Theoretical protection of infants for an easily treatable illness is simply not compelling enough to risk the pregnancy altogether.

Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth.

Share

Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Peter A. McCullough, MD, MPH

President, McCullough Foundation

www.mcculloughfnd.org

233

Share this post

Courageous Discourse™ with Dr. Peter McCullough & John Leake
Courageous Discourse™ with Dr. Peter McCullough & John Leake
Low RSV Vaccine Acceptance Among Pregnant Women
Copy link
Facebook
Email
Notes
More
21
20
Share

Discussion about this post

albert venezio
Jan 10, 2024

People are Waking Up to this Insanity!

Expand full comment
Reply
Share
Corrin Strong
Jan 10, 2024Edited

Does nobody in the medical profession remember the Thalidomide disaster? Do they even teach about it in Med School? This is insane! At least the average pregnant woman has more common sense than the FDA and the CDC!

Expand full comment
Reply
Share
2 replies
19 more comments...

No posts

Ready for more?

© 2025 Peter McCullough MD MPH
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More